Screen, Support, Survive: A New Era of Cancer Care with Color
During a recent tour of our membership, we asked employers about the top health conditions impacting their workforce. Every employer cited cancer among their top three concerns. With cancer affecting more people each year and treatment costs continuing to rise, the need for effective employer solutions has never been more urgent.
In this episode, we are joined by Dr. Rebecca Miksad, Chief Medical Officer at Color. Color is the first 50-state Virtual Cancer Clinic led by oncologists, delivering high-quality, patient-centered, and technology-enhanced care across the entire cancer care continuum—from screening, risk assessment, and prevention to diagnosis, treatment support, and survivorship.
Dr. Rebecca Miksad Chief Medical Officer Color Health Dr. Rebecca Miksad is a mission-driven Physician-Scientist with extensive expertise in cancer and patient-centric health technology and AI solutions. As Chief Medical Officer at Color Health, she oversees Color’s medical and clinical functions, driving the expansion of cancer screening, diagnostics, care navigation, and survivorship tools for program participants.
Dr. Miksad previously founded and led the Strategic Affairs team and Research Unit at Flatiron Health, developing pioneering healthtech products and establishing industry standards for real-world data. Her work has influenced FDA guidances and advanced Health Equity initiatives. With over 100 scientific publications, Dr. Miksad is an internationally recognized leader in oncology, clinical trials, and data science.
She established the first High Risk Cancer Genetics clinic at Boston Medical Center, where she is an Associate Professor and continues to care for patients. She previously directed the Gastrointestinal Cancer program at Beth Israel Deaconess Medical Center and conducted NIH-funded research. Clinically trained as a medical oncologist, Dr. Miksad holds an MD with Honors from Cornell University and an MPH in Clinical Effectiveness from Harvard University.
For more on her vision for impacting cancer at scale, you can read her personally penned article here. Her publications on PubMed can be found here.
Subscribe on your favorite streaming service to receive the latest updates on new episodes.
